NL-OMON36745
Not yet recruiting
Phase 4
Is antibiotic treatment associated with reduced risk of a subsequent exacerbation and mortality in chronic obstructive lung disease? A randomized clinical trial. - TEXACOLD trial
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Exacerbation COPD
- Sponsor
- Academisch Medisch Centrum
- Enrollment
- 2000
- Status
- Not yet recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Eligible for the cohort are patients aged \>\= 45 years, with a smoking history of \> 10 packyears and GOLD stage 1, 2 or 3; i.e. a post\-bronchodilator forced expiratory volume in one second (FEV1\)/forced vital capacity (FVC) ratio \< 0\.7, and FEV1 \> 30% \[30].
- •Patients will be included who had at least one documented episode of exacerbation during the past 3 years, with the restriction that treatment of the last exacerbation ended at least 4 week prior to inclusion in the study, and that symptoms returned to patient\*s baseline level.;In case of an exacerbation, patients will be randomized between doxycyclin 100 mg daily (1st day 200 mg), for 7 days, or placebo.
Exclusion Criteria
- •Excluded are patients with
- •\- poor cognitive functioning,
- •\- poor mastering of the Dutch language,
- •\- allergy for doxycyclin,
- •\- pregnancy,
- •\- a life expectancy less than one month.;In case of an exacerbation, patients will be randomized between doxycyclin and placebo.
- •Not eligible for randomization are patients
- •who should be treated with antibiotics according to the Dutch College of General Practitioners' guidelines for diagnosis and treatment of COPD and the Dutch multidisciplinary guideline for medical treatment of COPD (2008, NVALT/NHG): in case of symptoms of clinical infection (body temperature \> 38\.5C), or a low baseline expiratory flow rate (FEV1 \< 30%) \[21,42].
- •Patients who require hospitalization according to the ATS/ERS criteria \[44], who also should receive antibiotics.
- •Who currently use antibiotic therapy (including maintenance therapy).
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Is antibiotic treatment associated with reduced risk of a subsequent exacerbation and mortality in chronic obstructive lung disease? A randomized clinical trial.COPD, antibiotics, exacerbation, doxycyclinCOPD, antibiotica, exacerbatie, doxycyclineNL-OMON28324Academic Medical Center, Amsterdam470
Completed
Not Applicable
Reduction of antibiotic therapy by biomarkers in patients with CAP episodesPneumonia1000401810024970NL-OMON45194Medisch Centrum Alkmaar468
Recruiting
Phase 3
The effect of antibiotic therapy on the results of biopsy in meProstate Cancer.Malignant neoplasm of prostateIRCT20180915041037N1Yazd University of Medical Sciences80
Completed
Not Applicable
Can antibiotic prophylaxis reduce the rate of infection secondary to flexible cystoscopy and urodynamics?Infection and infestationsInfections and InfestationsInfection following cystoscopy or urodynamic investigationISRCTN37802560HS R&D Regional Programme Register - Department of Health (UK)
Not yet recruiting
Phase 4
Influence of antibiotic treatment on the normal flora and the presence of resistance genes in known carriers of ESBL and VRE2024-517434-17-01Region Uppsala60